The Handoff: Your Week in Neurology News - 3/23/17

The CDC says we should be paying more attention to fall-related concussion prevention in the elderly while one of the NFL's own heads to Harvard for a neurosurgery residency.

The Handoff: Your Week in Neurology News - 3/16/17

Marathon sells off its controversial DMD drug as the FDA stands to double its fees for the drug approval process under the new Trump budget.

The Handoff: Your Week in Neurology News - 3/9/17

The Obamacare replacement is here, and opposition is growing among medical groups. Plus, alternative medicine is having its moment at some major hospitals, while telemedicine proves to be a bust for health care costs.

The Handoff: Your Week in Neurology News - 3/2/17

While Genentech rolls the dice on a second phase 3 trial for its anti-amyloid agent, a new biotech startup is tapping CRISPR technology to restore dystrophin production in Duchenne muscular dystrophy.

The Handoff: Your Week in Neurology News - 2/23/17

Follow timely coverage of the International Stroke Conference right here on Neurology Advisor.

The Handoff: Your Week in Neurology News - 2/16/17

Just days after it received FDA approval, Marathon's Emflaza is under fire from critics who claim the price of the Duchenne muscular dystrophy drug is exorbitant.

The Handoff: Your Week in Neurology News - 2/9/17

Still feeling aftershocks from its failed Alzheimer's trial, Eli Lilly announced more layoffs while Biogen faces an investigation into its payment programs for its top MS drugs.

The Handoff: Your Week in Neurology News - 2/2/17

Traumatic brain injury continues to make major headlines as a new crop of lawsuits hit the docket ahead of Super Bowl LI. Plus, are we too quick to rush to in-human trials? The authors of an op-ed in Nature think so.

The Handoff: Your Week in Neurology News - 1/26/17

One US town tries to take Big Pharma to court over the opioid crisis while the FDA continues to approve new, abuse-deterrent opioids. Plus, the first patient with refractory mesial temporal lobe epilepsy has undergone laser ablation surgery as part of the SLATE trial.

The Handoff: Your Week in Neurology News - 1/19/17

UCB Pharma looks to expand its epilepsy drug as Biogen cuts a deal to protect Tecfidera, while insiders suggest that pharmacists should play a bigger role in managing the growing Alzheimer's dementia population.

Sign Up for Free e-newsletters